The MGME1 gene mitochondrial DNA depletion syndrome type 11 (MTDPS11) genetic test is a specialized diagnostic tool used to identify mutations in the MGME1 gene, which can lead to mitochondrial DNA depletion syndrome type 11. This condition is a rare autosomal recessive disorder characterized by a significant reduction in mitochondrial DNA within cells, leading to a variety of symptoms including muscle weakness, neurological problems, and other systemic issues.
The test is performed by extracting DNA from a patient's blood sample and analyzing it for specific mutations in the MGME1 gene that are known to cause the syndrome. This precise genetic testing is crucial for the accurate diagnosis of MTDPS11, enabling healthcare providers to tailor treatment plans to the specific needs of the patient, and also offers valuable information for family planning.
The cost of the MGME1 gene mitochondrial DNA depletion syndrome type 11 genetic test is 4400 AED. This test is available at DNA Labs UAE, a leading laboratory known for its advanced genetic testing services. DNA Labs UAE employs state-of-the-art technology and follows stringent protocols to ensure the accuracy and reliability of the test results, providing patients and their families with critical information for managing the condition.
The FBXL4 Gene Mitochondrial DNA Depletion Syndrome Type 13 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the FBXL4 gene, which are linked to Mitochondrial DNA Depletion Syndrome Type 13 (MTDPS13). This condition is a rare genetic disorder characterized by a significant reduction in mitochondrial DNA within cells, leading to a spectrum of clinical manifestations including muscle weakness, neurological impairments, and developmental delays, among others. The test is crucial for early diagnosis and management of the syndrome, enabling healthcare providers to tailor treatment plans to the specific needs of the patient.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient's DNA sample, usually obtained through a blood draw, to detect mutations in the FBXL4 gene. The cost of the test is 4400 AED, reflecting the comprehensive analysis and the sophisticated technology employed to ensure accurate diagnosis. By identifying the genetic basis of MTDPS13, this test plays a pivotal role in guiding clinical interventions and supporting families in understanding the implications of the disorder.
The POLG Gene Mitochondrial DNA Depletion Syndrome Type 4A Genetic Test is a specialized diagnostic assessment conducted at DNA Labs UAE, designed to identify mutations in the POLG gene. This gene plays a critical role in the replication and maintenance of mitochondrial DNA. Mutations in the POLG gene can lead to Mitochondrial DNA Depletion Syndrome Type 4A (MDDS4A), a rare genetic disorder characterized by muscle weakness, liver dysfunction, and neurological problems. The test involves collecting a DNA sample, typically through a blood draw, and analyzing it for specific genetic alterations associated with the syndrome. With a cost of 4400 AED, this genetic test is a crucial tool for early diagnosis and management of MDDS4A, allowing for personalized treatment plans and genetic counseling for affected individuals and their families.
The POLG Gene Mitochondrial DNA Depletion Syndrome Type 4B Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the POLG gene. This gene is crucial for the maintenance of mitochondrial DNA, and mutations can lead to mitochondrial DNA depletion syndrome type 4B (MDDS4B), a rare genetic disorder. The syndrome is characterized by a spectrum of clinical features, including neurological and muscular impairments, which can vary significantly in severity among affected individuals.
This genetic test is instrumental in confirming the diagnosis of MDDS4B, enabling healthcare professionals to provide targeted treatment and management plans for patients. By analyzing the patient's DNA, the test can identify specific mutations in the POLG gene that are responsible for the condition. Early diagnosis through genetic testing can be critical in managing symptoms and improving the quality of life for individuals with this syndrome.
The cost of the POLG Gene Mitochondrial DNA Depletion Syndrome Type 4B Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive analysis required to detect the presence of mutations in the POLG gene accurately. Given the complexity and the specialized nature of this test, it represents a crucial step towards personalized medicine for patients suspected of having MDDS4B or related mitochondrial disorders.
MPV17 Gene Mitochondrial DNA Depletion Syndrome Type 6 (MTDPS6) is a rare genetic disorder characterized by a significant reduction in mitochondrial DNA (mtDNA) in affected tissues, leading to a spectrum of clinical manifestations including liver dysfunction, neurological deficits, and muscle weakness. This condition is caused by mutations in the MPV17 gene, which plays a crucial role in the maintenance of mitochondrial DNA.
To diagnose this condition, a genetic test targeting the MPV17 gene can be conducted. This test is crucial for confirming the diagnosis, understanding the disease's progression, and for family planning purposes. DNA Labs UAE offers this specialized genetic testing service. The test involves analyzing the patient's DNA to identify mutations in the MPV17 gene that are responsible for Mitochondrial DNA Depletion Syndrome Type 6.
The cost of the MPV17 Gene Mitochondrial DNA Depletion Syndrome Type 6 Genetic Test at DNA Labs UAE is 4400 AED. This comprehensive test is conducted in a state-of-the-art laboratory setting by skilled geneticists and laboratory technicians. The process includes collecting a DNA sample, usually through a blood draw or cheek swab, followed by detailed analysis using advanced genetic sequencing technologies.
Upon completion of the test, a detailed report is provided to the patient or the ordering physician, outlining the findings and offering insights into the genetic makeup of the individual concerning the MPV17 gene. This information is vital for devising a personalized management plan for affected individuals and offers the possibility of genetic counseling for families.
The TWNK Gene Mitochondrial DNA Depletion Syndrome Type 7 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the TWNK gene, which are associated with Mitochondrial DNA Depletion Syndrome Type 7 (MTDPS7). MTDPS7 is a rare genetic condition characterized by a significant reduction in mitochondrial DNA within cells, leading to a spectrum of clinical manifestations including neurological and muscular impairments. The test plays a critical role in the early detection and management of the syndrome, allowing for tailored treatment strategies and genetic counseling for affected families. Priced at 4400 AED, this test is a crucial resource for individuals with a family history or clinical symptoms suggestive of MTDPS7, providing them with valuable insights into their genetic health.
The SUCLG1 Gene Mitochondrial DNA Depletion Syndrome Encephalomyopathic Type with Methylmalonic Aciduria Genetic Test is a specialized diagnostic assessment offered at DNA Labs UAE. This test is specifically designed to identify mutations in the SUCLG1 gene, which are known to cause a rare, inherited condition characterized by mitochondrial DNA depletion syndrome (MDS). The encephalomyopathic type of this syndrome is particularly severe, leading to neurological impairment, muscle weakness, and a range of other systemic symptoms. Additionally, affected individuals often exhibit methylmalonic aciduria, an abnormal accumulation of methylmalonic acid in the blood, which can lead to metabolic complications.
The test is conducted through a comprehensive analysis of the patient's DNA to detect any mutations in the SUCLG1 gene that are indicative of this condition. Early diagnosis through genetic testing is crucial for managing symptoms, preventing complications, and providing targeted treatments to improve the quality of life for affected individuals.
The cost of the SUCLG1 Gene Mitochondrial DNA Depletion Syndrome Encephalomyopathic Type with Methylmalonic Aciduria Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the detailed and specialized process of genetic analysis required to accurately diagnose this complex condition, enabling healthcare providers to devise an effective treatment plan tailored to the genetic profile of the patient.
The MFF Gene Mitochondrial Encephalomyopathy Genetic Test is a specialized diagnostic tool designed to identify mutations in the MFF gene, which are associated with mitochondrial encephalomyopathy. This condition is a group of disorders characterized by brain and muscle dysfunction, attributed to abnormalities in the mitochondria, the energy-producing structures within cells. Symptoms of mitochondrial encephalomyopathy can vary widely but often include muscle weakness, neurological deficits, and developmental delays.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient's DNA to detect specific mutations in the MFF gene that are linked to the development of mitochondrial encephalomyopathy. The process is non-invasive, requiring only a sample of blood or saliva from the patient.
The cost of the MFF Gene Mitochondrial Encephalomyopathy Genetic Test is 4400 AED. This investment covers the comprehensive analysis necessary to achieve a conclusive result, providing crucial information for the diagnosis, management, and potential treatment plans for individuals affected by or at risk of developing mitochondrial encephalomyopathy. It's an invaluable resource for families seeking answers and medical professionals looking for confirmation of this condition, facilitating targeted therapeutic interventions and supportive care strategies tailored to the patient's specific genetic makeup.
The MT-CYB Gene Mitochondrial Encephalomyopathy Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the MT-CYB gene, which is linked to mitochondrial encephalomyopathy. This condition is a group of disorders that affect the brain and nervous system, along with the muscles and other systems, and is caused by defects in the mitochondria, the energy-producing structures within cells. Mutations in the MT-CYB gene can lead to a variety of symptoms, including muscle weakness, exercise intolerance, heart problems, and neurological issues.
The test involves analyzing the patient's DNA to identify any genetic alterations in the MT-CYB gene that may be responsible for mitochondrial encephalomyopathy. Early detection through this genetic testing is crucial for managing symptoms, implementing appropriate treatments, and providing genetic counseling for affected families.
DNA Labs UAE offers this comprehensive genetic test for a cost of 4400 AED. The test is conducted in a state-of-the-art laboratory setting by skilled professionals who ensure accuracy and confidentiality of the results. Patients considering this test are advised to consult with a healthcare provider or a genetic counselor to understand the implications of the test results and to receive personalized advice based on their specific condition.
The "PUS1 Gene Mitochondrial Myopathy and Sideroblastic Anemia Type 1 Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the PUS1 gene. These mutations are responsible for a rare, inherited condition known as Mitochondrial Myopathy and Sideroblastic Anemia Type 1. This condition is characterized by a combination of muscle weakness (myopathy) and a form of anemia in which the bone marrow produces ringed sideroblasts instead of healthy red blood cells. Early and accurate diagnosis through this genetic test can be crucial for the management and treatment of the condition. The test is priced at 4400 AED and involves analyzing the patient's DNA to look for specific genetic alterations in the PUS1 gene, providing essential information for clinicians to develop an appropriate treatment plan.
